Zimmer Biomet director granted phantom stock units

Zimmer Biomet Holdings, Inc. director Maria Teresa Hilado received a grant of phantom stock units as part of her non-employee director compensation.

Rhea-AI Filing Summary

Zimmer Biomet Holdings, Inc. director Maria Teresa Hilado received a grant of phantom stock units as part of her non-employee director compensation. She acquired 378.873 phantom stock units tied on a 1-for-1 basis to common stock value, bringing her total phantom stock units to 11,684.719.

These units were accrued under the company’s Deferred Compensation Plan for Non-Employee Directors and will be settled in cash through ten annual installments starting within sixty days after the calendar year in which her board service ends. The total includes 30.381 units added earlier through the plan’s dividend reinvestment provision.

Insider Trade Summary

Grant/Award: 378.873 shares

Grant/Award 1 txn

Insider Hilado Maria Teresa

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	378.873	$0.00	$0.00

Holdings After Transaction: Phantom Stock Units — 11,684.719 contracts (Direct)

Footnotes (4)

1. F1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
2. F2. The Conversion or Exercise Price of Derivative Security is 1-for-1.
3. F3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
4. F4. Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Key Figures

Phantom stock units granted: 378.873 units Total phantom units after grant: 11,684.719 units Dividend reinvestment units: 30.381 units +3 more

6 metrics

Phantom stock units granted 378.873 units Grant to director on 2026-03-31

Total phantom units after grant 11,684.719 units Holdings following reported transaction

Dividend reinvestment units 30.381 units Accrued on January 30, 2026 via dividend reinvestment

Installment count 10 annual installments Cash settlement schedule after director service ends

Payout start window Within 60 days After end of calendar year of service cessation

Conversion ratio 1-for-1 Phantom stock units to Zimmer Biomet common stock value

Key Terms

Phantom Stock Units, Deferred Compensation Plan for Non-Employee Directors, dividend reinvestment provision

3 terms

Phantom Stock Units financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Deferred Compensation Plan for Non-Employee Directors financial

"The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

dividend reinvestment provision financial

"Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors."

A dividend reinvestment provision is a company policy that lets shareholders automatically use their cash dividends to buy more shares instead of receiving money. Think of it like a subscription that turns each payday into buying an extra slice of the same pie; it helps investors compound their holdings over time, often with lower transaction costs and sometimes at a small discount, which can boost long‑term returns and subtly change ownership percentages.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ZIMMER BIOMET (ZBH) director Maria Teresa Hilado report in this Form 4?

Maria Teresa Hilado reported receiving 378.873 phantom stock units as a compensation-related grant. These units track Zimmer Biomet common stock value and increased her total phantom stock holdings to 11,684.719 units under the company’s Deferred Compensation Plan for Non-Employee Directors.

What are phantom stock units in the context of ZIMMER BIOMET (ZBH)?

Phantom stock units are cash-settled awards whose value mirrors Zimmer Biomet common stock on a 1-for-1 basis. They are bookkeeping entries under the Deferred Compensation Plan for Non-Employee Directors, giving economic exposure to the stock without issuing actual shares.

How and when will Maria Teresa Hilado’s ZBH phantom stock units be paid out?

Her phantom stock units will be settled in cash over ten annual installments. Payments begin within sixty days after the end of the calendar year in which her service as a Zimmer Biomet director ceases, spreading the compensation over a multi-year period.

How many phantom stock units does Maria Teresa Hilado hold after this ZBH grant?

After the reported grant, she holds a total of 11,684.719 phantom stock units. This total includes the newly awarded 378.873 units and previously accrued amounts, such as 30.381 units added earlier through the plan’s dividend reinvestment provision.

What is the role of dividend reinvestment in ZBH’s phantom stock unit plan?

Under the dividend reinvestment provision, cash-equivalent dividends are credited as additional phantom stock units. For Hilado, this added 30.381 units on January 30, 2026, increasing her deferred compensation balance in line with dividends on Zimmer Biomet common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hilado Maria Teresa

(Last) (First) (Middle)

345 E. MAIN STREET

(Street)

WARSAW INDIANA 46580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units(1)	$89.08(2)	03/31/2026		A		378.873		(3)	(3)	Common Stock	378.873	$0	11,684.719(4)	D

Explanation of Responses:

1. The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

2. The Conversion or Exercise Price of Derivative Security is 1-for-1.

3. Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

4. Includes 30.381 phantom stock units accrued on January 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Theresa Maria Hilado (power of attorney previously filed)	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)